Primary record
Amisulpride; 4-Amino-N-[[(2RS)-1-ethylpyrrolidin-2-yl]methyl]-5-(ethylsulfonyl)-2-methoxybenzamide
- 库存
- 1,034 克
- 纯度
- 99.7 %
- CAS
- 71675-85-9
化合物标识与属性
- CAS
- 71675-85-9
- PubChem CID
- 2159
- SMILES
- CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC
- Canonical SMILES
- CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC
名称与同义词
- amisulpride
- Solian
- Aminosultopride
- Deniban
- 71675-85-9
- Amisulprida
- Amisulpridum
- Socian
- Amisulpiride
- Barhemsys
- Sulamid
- Sulpitac
- Amisulpride [INN]
- null
- Sultopride
- Topral
- ?Amisulpride
- Amisulpride/
- Amisulpride;
- Amisulpride?
- R-Amisulpride
- S-Amisulpride
- Aminosultopride;
- Amisulpride CRS
- Amisulpride free base
- Amisulpride-d5
- Deniban;
- Enorden;
- Majorem;
- Socian;
- Deniban (TN)
- Amisulpride (INN)
- (R)-Amisulpride
- Solian (TN)
- Barhemsys (TN)
- Amisulpridum [INN-Latin]
- DAN 2163
- (S)-Amisulpride?
- Solian, Amisulpride
- Amisulprida [INN-Spanish]
- Solian 50
- (plusmn)-amisulpride
- Amisulpride, (R)-
- APD421
- Solian 100
- Solian 200
- Solian 400
- Amisulpride [INN:BAN]
- PS24 - Amisulpride
- C17H27N3O4S
- Amisulpride (Standard)
- RefChem:56544
- AMISULPRIDE [MI]
- DAN-2163
- UNII-TC6N8QV7QO
- DTXSID5042613
- D03ELL
- AC1L1D1X
- APD-421
- AMISULPRIDE [MART.]
- MFCD00866691
- SCHEMBL34126
- (+/-)-AMISULPRIDE
- AMISULPRIDE [WHO-DD]
- DTXCID3022613
- GTPL963
- UNII-8110R61I4U
- CHEBI:64045
- MLS000758258
- MLS000759450
- MLS001424039
- MLS006011769
- NSC-760085
- Amisulpride for system suitability
- EINECS 275-831-7
- NTJOBXMMWNYJFB-UHFFFAOYSA-N
- CHEMBL243712
- orb1310270
- 71675-85-9 (free base)
- 8110R61I4U
- Amisulpride - Bio-X trade mark
- Amisulpride, 98% - 1G 1g
- SCHEMBL29506665
- Amisulpride, >=98% (HPLC)
- Amisulpride, 1mg/ml in Methanol
- BDBM81790
- CTK8B3282
- AMISULPRIDE [ORANGE BOOK]
- CID2159
- N05AL05
- Solian, 71675-85-9
- AMISULPRIDE [EP MONOGRAPH]
- BCPP000404
- HMS2051K10
- HMS2235M16
- HMS3263D07
- HMS3268L09
- HMS3369K09
- HMS3393K10
- HMS3413G07
- HMS3657E11
- HMS3677G07
- HMS3713N06
- HMS3884A09
- HMS5079J05
- Pharmakon1600-01502285
- BCP02089
- KS-00000XK6
- MSK10508
- NSC_2159
- WCA67590
- WCA67592
- 4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide
- Tox21_113392
- Tox21_501133
- ABP000597
- ANW-42197
- C17-H27-N3-O4-S
- CA0133
- EBC-11187
- FC0018
- HB1879
- HY-14545R
- NCGC00092310-03
- NP2928
- NSC760085
- STK635172
- STL454297
- 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide
- AKOS005567252
- Amisulpride for system suitability CRS
- Tox21_113392_1
- AC-6820
- AN-6961
- BCP9000294
- CCG-100860
- CCG-220622
- CCG-222437
- CS-1791
- CS-O-11594
- DB06288
- FA17868
- LP01133
- LS41262
- NC00110
- NSC 760085
- RL04735
- SDCCGSBI-0633795.P001
- NCGC00092310-01
- NCGC00092310-02
- NCGC00092310-04
- NCGC00092310-06
- NCGC00092310-16
- NCGC00261818-01
- SL-91.1077
- AS-13890
- BA164158
- CPD000449309
- HY-14545
- J18.603A
- K214
- LS-25532
- SAM001246639
- SAM001246966
- SC-23161
- SMR000449309
- SY052770
- 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-o-anisamide
- Amisulpride 100 microg/mL in Acetonitrile
- 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide
- 4-amino-N-((1-ethylpyrrolidin-2-yl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide
- AB0008029
- AB1009624
- CAS-71675-85-9
- CAS_71675-85-9
- A2450
- AK00472461
- FT-0630805
- NS00000416
- S1280
- SW197490-3
- D07310
- AB00639933-07
- AB00639933-09
- AB00639933_10
- 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-anisamid
- 675A859
- A837282
- EN300-18166870
- L000106
- Q418785
- SR-01000759303
- 4-amino-5-(ethanesulfonyl)-N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxybenzamide
- 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide
- I06-0334
- SR-01000759303-5
- Benzamide, 4-amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxy-
- BRD-A60197193-001-05-4
- BRD-A60197193-001-13-8
- BRD-A60197193-001-14-6
- Amisulpride, British Pharmacopoeia (BP) Reference Standard
- Amisulpride, European Pharmacopoeia (EP) Reference Standard
- 53583-79-2
- 71675-90-6
- 3,3-bis(methylthio)-2-[3-(trifluoromethyl)benzoyl]acrylonitrile
- 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxy-benzamide
- 4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-benzamide
- 4-amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-o-anisamide
- 71675-92-8
- 4-amino-5-(ethanesulfonyl)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-methoxybenzamide
- 4-amino-5-ethanesulfonyl-n-(1-ethyl-pyrrolidin-2-ylmethyl)-2-methoxy-benzamide
- 4-amino-N-((1-ethylpyrrolidin-2-yl)methyl)-5-ethylsulfonyl-2-methoxybenzamide
- 4-Amino-N-[(1-ethyl-2 pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide
- 4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulf onyl)-2-benzamide DAN 2163
- 4-Amino-N-[(1-Ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)- 2-methoxybenzamide
- 4-amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-ethylsulfonyl-2-methoxybenzamide
- 4-amino-N-[[(2R)-1-ethylpyrrolidin-2-yl]methyl]-5-ethylsulfonyl-2-methoxybenzamide
- Amisulpride for system suitability, European Pharmacopoeia (EP) Reference Standard
- 1216626-17-3
- 275-831-7
- 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-(ethylsulfonyl)-2-methoxybenzenecarboximidic acid
- Amisulpride; 4-Amino-N-[[(2RS)-1-ethylpyrrolidin-2-yl]methyl]-5-(ethylsulfonyl)-2-methoxybenzamide